CN1319582C - 一种用于治疗湿热症的中药溶液剂及其制备方法和其用途 - Google Patents
一种用于治疗湿热症的中药溶液剂及其制备方法和其用途 Download PDFInfo
- Publication number
- CN1319582C CN1319582C CNB2005100085000A CN200510008500A CN1319582C CN 1319582 C CN1319582 C CN 1319582C CN B2005100085000 A CNB2005100085000 A CN B2005100085000A CN 200510008500 A CN200510008500 A CN 200510008500A CN 1319582 C CN1319582 C CN 1319582C
- Authority
- CN
- China
- Prior art keywords
- solution
- vaginitis
- ethanol
- solubilizing agent
- borneolum syntheticum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 46
- 238000000034 method Methods 0.000 title claims abstract description 22
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract description 12
- 201000010099 disease Diseases 0.000 title abstract description 11
- 239000003795 chemical substances by application Substances 0.000 title description 4
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 26
- 206010047799 Vulvovaginitis trichomonal Diseases 0.000 claims abstract description 20
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 19
- 206010046914 Vaginal infection Diseases 0.000 claims abstract description 17
- 201000008100 Vaginitis Diseases 0.000 claims abstract description 14
- 208000004926 Bacterial Vaginosis Diseases 0.000 claims abstract description 11
- 230000003628 erosive effect Effects 0.000 claims abstract description 8
- 206010008323 cervicitis Diseases 0.000 claims abstract description 7
- 208000006374 Uterine Cervicitis Diseases 0.000 claims abstract description 6
- 239000003937 drug carrier Substances 0.000 claims abstract description 5
- 206010003693 Atrophic vulvovaginitis Diseases 0.000 claims abstract description 3
- 201000010808 postmenopausal atrophic vaginitis Diseases 0.000 claims abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 68
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 24
- -1 fatty acid ester Chemical class 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- 208000011580 syndromic disease Diseases 0.000 claims description 21
- 239000002904 solvent Substances 0.000 claims description 19
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 18
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 14
- 239000000706 filtrate Substances 0.000 claims description 13
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 11
- 239000006184 cosolvent Substances 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- 229920001214 Polysorbate 60 Polymers 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical class C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims description 8
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 8
- 229930195729 fatty acid Natural products 0.000 claims description 8
- 239000000194 fatty acid Substances 0.000 claims description 8
- 238000005325 percolation Methods 0.000 claims description 8
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 8
- 229920000053 polysorbate 80 Polymers 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- 240000007926 Ocimum gratissimum Species 0.000 claims description 7
- 239000004480 active ingredient Substances 0.000 claims description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 6
- 235000010676 Ocimum basilicum Nutrition 0.000 claims description 6
- 239000004615 ingredient Substances 0.000 claims description 6
- 238000002386 leaching Methods 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 5
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 claims description 5
- 239000004334 sorbic acid Substances 0.000 claims description 5
- 235000010199 sorbic acid Nutrition 0.000 claims description 5
- 229940075582 sorbic acid Drugs 0.000 claims description 5
- 229920001219 Polysorbate 40 Polymers 0.000 claims description 4
- 229920002651 Polysorbate 85 Polymers 0.000 claims description 4
- 239000008367 deionised water Substances 0.000 claims description 4
- 229910021641 deionized water Inorganic materials 0.000 claims description 4
- 239000012153 distilled water Substances 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 4
- 229960003511 macrogol Drugs 0.000 claims description 4
- 229920001993 poloxamer 188 Polymers 0.000 claims description 4
- 229920000191 poly(N-vinyl pyrrolidone) Polymers 0.000 claims description 4
- 235000010483 polyoxyethylene sorbitan monopalmitate Nutrition 0.000 claims description 4
- 239000000249 polyoxyethylene sorbitan monopalmitate Substances 0.000 claims description 4
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 claims description 4
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 claims description 4
- 229940101027 polysorbate 40 Drugs 0.000 claims description 4
- 229940113124 polysorbate 60 Drugs 0.000 claims description 4
- 229940113171 polysorbate 85 Drugs 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 238000013019 agitation Methods 0.000 claims description 3
- 238000005520 cutting process Methods 0.000 claims description 3
- 241000545442 Radix Species 0.000 claims description 2
- 239000012141 concentrate Substances 0.000 claims description 2
- 238000000151 deposition Methods 0.000 claims description 2
- 230000003612 virological effect Effects 0.000 claims description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 31
- 208000003251 Pruritus Diseases 0.000 abstract description 26
- 238000002360 preparation method Methods 0.000 abstract description 20
- 244000045947 parasite Species 0.000 abstract description 17
- 206010061218 Inflammation Diseases 0.000 abstract description 8
- 230000004054 inflammatory process Effects 0.000 abstract description 7
- 230000007803 itching Effects 0.000 abstract description 7
- 230000008961 swelling Effects 0.000 abstract description 7
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 241000972673 Phellodendron amurense Species 0.000 abstract description 2
- 230000008901 benefit Effects 0.000 abstract description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 abstract 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 240000003705 Senecio vulgaris Species 0.000 abstract 1
- 241000219784 Sophora Species 0.000 abstract 1
- 241001671204 Stemona Species 0.000 abstract 1
- 229940018006 basil oil Drugs 0.000 abstract 1
- 239000010619 basil oil Substances 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- 230000009194 climbing Effects 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 230000007794 irritation Effects 0.000 abstract 1
- 229940041616 menthol Drugs 0.000 abstract 1
- 230000001018 virulence Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 63
- 238000012360 testing method Methods 0.000 description 28
- 230000002147 killing effect Effects 0.000 description 21
- 230000001225 therapeutic effect Effects 0.000 description 15
- 229940079593 drug Drugs 0.000 description 14
- 230000000844 anti-bacterial effect Effects 0.000 description 13
- 230000002401 inhibitory effect Effects 0.000 description 12
- 230000036407 pain Effects 0.000 description 12
- 244000052616 bacterial pathogen Species 0.000 description 11
- 210000001215 vagina Anatomy 0.000 description 11
- 241000191967 Staphylococcus aureus Species 0.000 description 10
- 241000894006 Bacteria Species 0.000 description 9
- 230000002411 adverse Effects 0.000 description 9
- 230000003115 biocidal effect Effects 0.000 description 9
- 241000222122 Candida albicans Species 0.000 description 8
- 241000588724 Escherichia coli Species 0.000 description 7
- 230000003110 anti-inflammatory effect Effects 0.000 description 7
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 6
- 241000194017 Streptococcus Species 0.000 description 6
- 230000001139 anti-pruritic effect Effects 0.000 description 6
- 230000001572 anti-trichomonad Effects 0.000 description 6
- 239000003908 antipruritic agent Substances 0.000 description 6
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 6
- 229940093265 berberine Drugs 0.000 description 6
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 6
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 6
- 230000002949 hemolytic effect Effects 0.000 description 6
- 239000008921 jie er yin Substances 0.000 description 6
- 231100000614 poison Toxicity 0.000 description 6
- 239000003440 toxic substance Substances 0.000 description 6
- 206010007134 Candida infections Diseases 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 5
- 201000004624 Dermatitis Diseases 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 208000010668 atopic eczema Diseases 0.000 description 5
- 201000003984 candidiasis Diseases 0.000 description 5
- 208000001848 dysentery Diseases 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 239000012567 medical material Substances 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 239000000829 suppository Substances 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 241000193830 Bacillus <bacterium> Species 0.000 description 4
- 229960000583 acetic acid Drugs 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 239000000575 pesticide Substances 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- 210000003905 vulva Anatomy 0.000 description 4
- 206010063409 Acarodermatitis Diseases 0.000 description 3
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 3
- 239000005770 Eugenol Substances 0.000 description 3
- ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 description 3
- ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical compound C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 description 3
- 241000588653 Neisseria Species 0.000 description 3
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 241000447727 Scabies Species 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 229940095731 candida albicans Drugs 0.000 description 3
- 238000002648 combination therapy Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000007938 effervescent tablet Substances 0.000 description 3
- 206010014881 enterobiasis Diseases 0.000 description 3
- 229960002217 eugenol Drugs 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 238000011010 flushing procedure Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 230000009545 invasion Effects 0.000 description 3
- 239000002398 materia medica Substances 0.000 description 3
- 229930014456 matrine Natural products 0.000 description 3
- 210000004877 mucosa Anatomy 0.000 description 3
- 239000003507 refrigerant Substances 0.000 description 3
- 208000005687 scabies Diseases 0.000 description 3
- 231100000019 skin ulcer Toxicity 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- XQXPVVBIMDBYFF-UHFFFAOYSA-N 4-hydroxyphenylacetic acid Chemical compound OC(=O)CC1=CC=C(O)C=C1 XQXPVVBIMDBYFF-UHFFFAOYSA-N 0.000 description 2
- 206010010071 Coma Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 208000016908 Female Genital disease Diseases 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 241000517307 Pediculus humanus Species 0.000 description 2
- 208000008350 Pruritus Vulvae Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000019802 Sexually transmitted disease Diseases 0.000 description 2
- 208000037009 Vaginitis bacterial Diseases 0.000 description 2
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229940126678 chinese medicines Drugs 0.000 description 2
- 230000002079 cooperative effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 239000002547 new drug Substances 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 229920001983 poloxamer Polymers 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- RLQYRXCUPVKSAW-UHFFFAOYSA-M 2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium;chloride Chemical compound [Cl-].COC1=C(OC)C=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=C1 RLQYRXCUPVKSAW-UHFFFAOYSA-M 0.000 description 1
- XVPBINOPNYFXID-JARXUMMXSA-N 85u4c366qs Chemical compound C([C@@H]1CCC[N@+]2(CCC[C@H]3[C@@H]21)[O-])N1[C@@H]3CCCC1=O XVPBINOPNYFXID-JARXUMMXSA-N 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- IUIVPFWDRADZFL-UHFFFAOYSA-N C(C1=CC=CC=C1)C1=NC=CC=N1.CON Chemical compound C(C1=CC=CC=C1)C1=NC=CC=N1.CON IUIVPFWDRADZFL-UHFFFAOYSA-N 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- 241000498255 Enterobius vermicularis Species 0.000 description 1
- 241001248531 Euchloe <genus> Species 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 241000207201 Gardnerella vaginalis Species 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 235000004066 Ocimum gratissimum Nutrition 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010033971 Paratyphoid fever Diseases 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 241001079007 Phellodendron chinense Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000517304 Pthirus pubis Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 241001146210 Senecio scandens Species 0.000 description 1
- 241000246044 Sophora flavescens Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 241000417534 Stemona sessilifolia Species 0.000 description 1
- 241000411860 Stemona tuberosa Species 0.000 description 1
- 241000244978 Stemonaceae Species 0.000 description 1
- 240000007267 Stephania hernandifolia Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 241000193990 Streptococcus sp. 'group B' Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 240000004460 Tanacetum coccineum Species 0.000 description 1
- 229920002253 Tannate Polymers 0.000 description 1
- 208000007074 Trichomonas Vaginitis Diseases 0.000 description 1
- 241000224527 Trichomonas vaginalis Species 0.000 description 1
- 208000025206 Trichomonas vaginitis urogenital infection Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- AXMVYSVVTMKQSL-UHFFFAOYSA-N UNPD142122 Natural products OC1=CC=C(C=CC=O)C=C1O AXMVYSVVTMKQSL-UHFFFAOYSA-N 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 235000009392 Vitis Nutrition 0.000 description 1
- 241000219095 Vitis Species 0.000 description 1
- 201000007096 Vulvovaginal Candidiasis Diseases 0.000 description 1
- 206010048245 Yellow skin Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- ROVGZAWFACYCSP-MQBLHHJJSA-N [2-methyl-4-oxo-3-[(2z)-penta-2,4-dienyl]cyclopent-2-en-1-yl] (1r,3r)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OC1C(C)=C(C\C=C/C=C)C(=O)C1 ROVGZAWFACYCSP-MQBLHHJJSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- CKMXBZGNNVIXHC-UHFFFAOYSA-L ammonium magnesium phosphate hexahydrate Chemical compound [NH4+].O.O.O.O.O.O.[Mg+2].[O-]P([O-])([O-])=O CKMXBZGNNVIXHC-UHFFFAOYSA-L 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000003260 anti-sepsis Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 208000002352 blister Diseases 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000002026 carminative effect Effects 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229940097572 chloromycetin Drugs 0.000 description 1
- 201000003988 chronic cervicitis Diseases 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- RIDQRIPSFYHEGL-UHFFFAOYSA-N fibrauretin Natural products CC12CC=C3C(=O)OC(CC3(C)C1C(=O)C=CC2=O)c4cocc4 RIDQRIPSFYHEGL-UHFFFAOYSA-N 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 229930015582 oxymatrine Natural products 0.000 description 1
- 231100000255 pathogenic effect Toxicity 0.000 description 1
- JLFNLZLINWHATN-UHFFFAOYSA-N pentaethylene glycol Chemical compound OCCOCCOCCOCCOCCO JLFNLZLINWHATN-UHFFFAOYSA-N 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000007965 phenolic acids Chemical group 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229950008882 polysorbate Drugs 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001915 proofreading effect Effects 0.000 description 1
- YQUVCSBJEUQKSH-UHFFFAOYSA-N protochatechuic acid Natural products OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229940015367 pyrethrum Drugs 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 229910052567 struvite Inorganic materials 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- WKOLLVMJNQIZCI-UHFFFAOYSA-N vanillic acid Chemical compound COC1=CC(C(O)=O)=CC=C1O WKOLLVMJNQIZCI-UHFFFAOYSA-N 0.000 description 1
- TUUBOHWZSQXCSW-UHFFFAOYSA-N vanillic acid Natural products COC1=CC(O)=CC(C(O)=O)=C1 TUUBOHWZSQXCSW-UHFFFAOYSA-N 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 208000002003 vulvitis Diseases 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
治疗效果 | 试验组 | 对照组 |
总有效率痊愈率显效率有效率 | 91.1%25.6%47.8%17.8% | 87.2%21.1%42.2%23.9% |
对致病菌的清除效果 | 试验组 | 对照组 |
致病菌的总清除率滴虫清除率念珠菌清除率细菌清除率 | 81.9%89.9%84.7%71.2% | 76.1%88.3%73.7%66.1% |
治疗效果 | 试验组 | 对照组 |
总有效率痊愈率显效率有效率 | 94.4%9.0%64.9%22.2% | 91.7%,8.5%58.1%27.4% |
对病菌的清除效果 | 试验组 | 对照组 |
致病菌的总清除率滴虫清除率念珠菌清除率细菌清除率 | 87.7%90.7%85.0%87.3% | 85.5%92.5%73.7%89.7% |
Claims (23)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100085000A CN1319582C (zh) | 2005-02-23 | 2005-02-23 | 一种用于治疗湿热症的中药溶液剂及其制备方法和其用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100085000A CN1319582C (zh) | 2005-02-23 | 2005-02-23 | 一种用于治疗湿热症的中药溶液剂及其制备方法和其用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1682813A CN1682813A (zh) | 2005-10-19 |
CN1319582C true CN1319582C (zh) | 2007-06-06 |
Family
ID=35262432
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100085000A Active CN1319582C (zh) | 2005-02-23 | 2005-02-23 | 一种用于治疗湿热症的中药溶液剂及其制备方法和其用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1319582C (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102847028A (zh) * | 2012-04-17 | 2013-01-02 | 霸王(广州)有限公司 | 一种中药消毒剂及其制备方法 |
CN103381253B (zh) * | 2013-06-27 | 2015-03-25 | 黄文珍 | 治疗女性外阴瘙痒的中药组合物及其制备方法 |
CN106267329B (zh) * | 2016-08-15 | 2019-04-23 | 湖南仁馨生物技术有限公司 | 一种植物精油凝胶敷料及其制备方法和应用 |
CN108542604A (zh) * | 2018-03-29 | 2018-09-18 | 福建美可纸业有限公司 | 一种驱蚊纸尿裤 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1116047A (zh) * | 1994-08-03 | 1996-02-07 | 柳州柳瑞旅游保健卫生制品厂 | 消毒液 |
CN1223142A (zh) * | 1998-11-17 | 1999-07-21 | 杜仲成 | 妇科病防治液及其制备方法 |
CN1519001A (zh) * | 2003-01-24 | 2004-08-11 | 刘俊田 | 用于治疗女性生殖系统炎症的中药外用洗剂 |
-
2005
- 2005-02-23 CN CNB2005100085000A patent/CN1319582C/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1116047A (zh) * | 1994-08-03 | 1996-02-07 | 柳州柳瑞旅游保健卫生制品厂 | 消毒液 |
CN1223142A (zh) * | 1998-11-17 | 1999-07-21 | 杜仲成 | 妇科病防治液及其制备方法 |
CN1519001A (zh) * | 2003-01-24 | 2004-08-11 | 刘俊田 | 用于治疗女性生殖系统炎症的中药外用洗剂 |
Also Published As
Publication number | Publication date |
---|---|
CN1682813A (zh) | 2005-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100542585C (zh) | 一种具有镇痛和抗炎作用的外用药物组合物 | |
CN1739638A (zh) | 一种治疗皮肤病的药物及其制备方法 | |
CN103110868A (zh) | 一种皮肤护理液及其制备方法 | |
CN103800772A (zh) | 一种防治阴道炎症的妇科外用洗液及其制备方法 | |
US10478463B2 (en) | External-use medicament for cleaning and care of the ovaries, vagina, and vulva | |
CN104547303A (zh) | 一种治疗妇科炎症的外用凝胶剂及其制备方法 | |
CN1319582C (zh) | 一种用于治疗湿热症的中药溶液剂及其制备方法和其用途 | |
CN103656369A (zh) | 一种防治银屑病复方药 | |
CN101040957A (zh) | 治疗湿疹及皮炎类皮肤病的药物及其制备方法 | |
CN1251748C (zh) | 治疗妇科疾病的洗剂及其制备方法 | |
CN101810721B (zh) | 一种治疗多种妇科疾病的药物组合物及其制备方法 | |
CN101623368A (zh) | 一种治疗妇科疾病的药物及其制备工艺 | |
CN109908304B (zh) | 中药组合物及其用途、外用中药制剂及其制备方法 | |
CN1958060A (zh) | 具有消炎抑菌作用的洗涤皂 | |
CN1330362C (zh) | 祛伤消肿酊及其制备方法 | |
CN1278709C (zh) | 一种治疗感冒的药物及其制备方法 | |
CN113181336A (zh) | 一种治疗妇科疾病的中药组合物、制剂及其制备方法和应用 | |
CN113813308A (zh) | 一种治疗烧烫伤的药物及其制备方法 | |
CN1219527C (zh) | 治疗痤疮的软膏及其制备方法 | |
CN109331134A (zh) | 一种治疗犬猫耳螨病的中药及其制备方法 | |
CN116832125B (zh) | 一种中药组合物、制备方法及其应用 | |
CN102988847A (zh) | 一种治疗阴道炎的药物组合物 | |
CN116832128B (zh) | 一种治疗皮肤湿疹糜烂的中药复方及其应用 | |
CN1262292C (zh) | 一种药物组合物、其制备方法及其在制备治疗妇科疾病药物中的应用 | |
CN106074995A (zh) | 一种用于治疗女性生殖器炎症的抗菌组合物及其用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: JIANGXI YAODU RENHE PHARMACEUTICAL CO., LTD. Free format text: FORMER NAME: HUANG DEZHONG |
|
CP03 | Change of name, title or address |
Address after: No. 29, medicine road, Zhangshu City, Jiangxi Province Patentee after: Jiangxi Pharmaceutical Co., Ltd. Address before: With the street and South Street South South Lake manor in Guangdong province Guangzhou City No. 4 first floor Patentee before: Huang Dezhong |
|
C56 | Change in the name or address of the patentee | ||
CP02 | Change in the address of a patent holder |
Address after: 100005, room 1, building 7, Guanghua building, No. 1116, inner Jianguomen Avenue, Beijing, Dongcheng District, Changan Patentee after: Jiangxi Pharmaceutical Co., Ltd. Address before: 331200 No. 29 medicine road, Zhangshu City, Jiangxi Province Patentee before: Jiangxi Pharmaceutical Co., Ltd. |